- Patent Title: Pharmaceutical composition for a sustained release of lanreotide
-
Application No.: US14903010Application Date: 2014-07-08
-
Publication No.: US10543249B2Publication Date: 2020-01-28
- Inventor: Ruth Bielsa Guivernau , Roland Cherif-Cheikh , Julie Fournes , Daniel Martinez Lorente , Anne Petit , Joël Richard
- Applicant: IPSEN PHARMA S.A.S.
- Applicant Address: FR Boulogne-Billancourt
- Assignee: IPSEN PHARMA S.A.S.
- Current Assignee: IPSEN PHARMA S.A.S.
- Current Assignee Address: FR Boulogne-Billancourt
- Agency: Barnes & Thornburg LLP
- Agent Gene J. Yao
- Priority: EP13290156 20130709
- International Application: PCT/EP2014/064586 WO 20140708
- International Announcement: WO2015/004125 WO 20150115
- Main IPC: A61K38/08
- IPC: A61K38/08 ; A61K9/00 ; A61K47/12
Abstract:
A pharmaceutical composition for a sustained release of peptide therapeutics, in particular for a sustained release compatible with therapeutic treatments of at least two months. In an embodiment, the composition comprises lanreotide as an active agent, a hydrosoluble co-solvent, and water with the pH of the composition being from 4.0 to 7.5.
Public/Granted literature
- US20160151447A1 PHARMACEUTICAL COMPOSITION FOR A SUSTAINED RELEASE OF LANREOTIDE Public/Granted day:2016-06-02
Information query
IPC分类:
